1098 related articles for article (PubMed ID: 3936214)
1. Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.
Browne MJ; Dodd I; Carey JE; Chapman CG; Robinson JH
Thromb Haemost; 1985 Aug; 54(2):422-4. PubMed ID: 3936214
[TBL] [Abstract][Full Text] [Related]
2. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
3. Expression of human tissue-type plasminogen activator from lytic viral vectors and in established cell lines.
Sambrook J; Hanahan D; Rodgers L; Gething MJ
Mol Biol Med; 1986 Dec; 3(6):459-81. PubMed ID: 3039288
[TBL] [Abstract][Full Text] [Related]
4. Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.
Dodd I; Fears R; Robinson JH
Thromb Haemost; 1986 Feb; 55(1):94-7. PubMed ID: 3085269
[TBL] [Abstract][Full Text] [Related]
5. The tissue-type plasminogen activator story.
Collen D; Lijnen HR
Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
[TBL] [Abstract][Full Text] [Related]
6. Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site.
Dodd I; Nunn B; Robinson JH
Thromb Haemost; 1988 Jun; 59(3):523-8. PubMed ID: 3142086
[TBL] [Abstract][Full Text] [Related]
7. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.
Stack MS; Gray RD; Pizzo SV
Cancer Res; 1993 May; 53(9):1998-2004. PubMed ID: 8481902
[TBL] [Abstract][Full Text] [Related]
8. Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli.
Harris TJ; Patel T; Marston FA; Little S; Emtage JS; Opdenakker G; Volckaert G; Rombauts W; Billiau A; De Somer P
Mol Biol Med; 1986 Jun; 3(3):279-92. PubMed ID: 3090401
[TBL] [Abstract][Full Text] [Related]
9. A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA).
Gaffney PJ; Curtis AD
Thromb Haemost; 1987 Dec; 58(4):1085-7. PubMed ID: 3127919
[TBL] [Abstract][Full Text] [Related]
10. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
11. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
Hagège J; Delarue F; Peraldi MN; Sraer JD; Rondeau E
Lab Invest; 1994 Dec; 71(6):828-37. PubMed ID: 7807964
[TBL] [Abstract][Full Text] [Related]
12. On the role of C1-inhibitor as inhibitor of tissue-type plasminogen activator in human plasma.
Huisman LG; van Griensven JM; Kluft C
Thromb Haemost; 1995 Mar; 73(3):466-71. PubMed ID: 7667830
[TBL] [Abstract][Full Text] [Related]
13. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
14. Cultivation of Bowes melanoma cells in the Opticell system: influence of the addition of protein supplements to the serum-free medium on the production of plasminogen activator.
Bödeker BG; Klimetzek V; Klein U; Hewlett G; Schlumberger HD
Dev Biol Stand; 1987; 66():291-7. PubMed ID: 3108052
[TBL] [Abstract][Full Text] [Related]
15. The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation.
Kassam G; Le BH; Choi KS; Kang HM; Fitzpatrick SL; Louie P; Waisman DM
Biochemistry; 1998 Dec; 37(48):16958-66. PubMed ID: 9836589
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
17. Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.
Tran-Thang C; Vouillamoz D; Kruithof EK; Sordat B
J Cell Physiol; 1994 Nov; 161(2):285-92. PubMed ID: 7962113
[TBL] [Abstract][Full Text] [Related]
18. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
19. Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells.
Larsson P; Ulfhammer E; Karlsson L; Bokarewa M; Wåhlander K; Jern S
Thromb Res; 2008; 123(2):342-51. PubMed ID: 18502475
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
Collen D; Stassen JM; Marafino BJ; Builder S; De Cock F; Ogez J; Tajiri D; Pennica D; Bennett WF; Salwa J
J Pharmacol Exp Ther; 1984 Oct; 231(1):146-52. PubMed ID: 6541693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
